Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.25584 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.16588 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.16587 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.26932 | 54 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.0926 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.36661 | 52 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.31278 | 51 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.21983 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.1174 | 48 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.14175 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.15354 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.09571 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.20991 | 50 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.17597 | 49 |